Lemaitre Vascular Stock EBITDA

LMAT Stock

USD 106.99 1.19 1.12%

LeMaitre Vascular fundamentals help investors to digest information that contributes to LeMaitre Vascular's financial success or failures. It also enables traders to predict the movement of LeMaitre Stock. The fundamental analysis module provides a way to measure LeMaitre Vascular's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to LeMaitre Vascular stock.

		Last Reported	Projected for Next Year
	EBITDA	49 M	51.4 M

EBITDA is likely to gain to about 51.4 M in 2024.

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

LeMaitre Vascular Company EBITDA Analysis

LeMaitre Vascular's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

EBITDA

Revenue

-

Basic Expenses

More About EBITDA | All Equity Analysis

Current LeMaitre Vascular EBITDA

48.99 M

Most of LeMaitre Vascular's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, LeMaitre Vascular is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

LeMaitre EBITDA Driver Correlations

Understanding the fundamental principles of building solid financial models for LeMaitre Vascular is extremely important. It helps to project a fair market value of LeMaitre Stock properly, considering its historical fundamentals such as EBITDA. Since LeMaitre Vascular's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of LeMaitre Vascular's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of LeMaitre Vascular's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Total Liab	Total Current Assets	Short Term Debt	Current Deferred Revenue	Retained Earnings	Accounts Payable	Long Term Debt	Net Receivables	Good Will	Short Term Investments	Treasury Stock	Intangible Assets	Common Stock	Property Plant Equipment	Net Tangible Assets	Capital Surpluse	Deferred Long Term Liab	Net Invested Capital	Net Working Capital	Capital Stock	Short Long Term Debt
Total Assets		0.99	0.5	0.84	0.97	0.53	0.32	0.99	0.96	0.9	0.83	0.98	0.9	-0.8	0.92	0.74	0.89	0.99	0.86	-0.74	0.93	0.83	0.93	-0.63
Total Stockholder Equity	0.99		0.41	0.77	0.99	0.48	0.24	0.98	0.96	0.87	0.82	0.96	0.93	-0.8	0.87	0.74	0.89	0.98	0.87	-0.73	0.93	0.86	0.95	-0.64
Net Debt	0.5	0.41		0.79	0.31	0.43	0.77	0.51	0.44	0.57	0.39	0.63	0.24	-0.25	0.74	0.16	0.43	0.47	0.4	-0.5	0.57	0.27	0.44	-0.11
Total Liab	0.84	0.77	0.79		0.71	0.7	0.61	0.82	0.8	0.84	0.75	0.9	0.54	-0.7	0.93	0.63	0.69	0.79	0.63	-0.6	0.77	0.5	0.68	-0.4
Total Current Assets	0.97	0.99	0.31	0.71		0.43	0.13	0.97	0.97	0.85	0.79	0.91	0.95	-0.77	0.8	0.72	0.85	0.98	0.84	-0.7	0.89	0.86	0.94	-0.71
Short Term Debt	0.53	0.48	0.43	0.7	0.43		0.35	0.45	0.43	0.41	0.71	0.6	0.21	-0.63	0.67	0.66	0.42	0.42	0.53	-0.27	0.57	0.39	0.33	-0.05
Current Deferred Revenue	0.32	0.24	0.77	0.61	0.13	0.35		0.31	0.23	0.46	0.36	0.47	0.01	-0.34	0.59	0.31	0.49	0.26	0.26	-0.32	0.32	0.0	0.16	0.2
Retained Earnings	0.99	0.98	0.51	0.82	0.97	0.45	0.31		0.96	0.92	0.81	0.97	0.91	-0.75	0.89	0.69	0.88	1.0	0.85	-0.77	0.93	0.83	0.93	-0.64
Accounts Payable	0.96	0.96	0.44	0.8	0.97	0.43	0.23	0.96		0.88	0.78	0.92	0.89	-0.77	0.82	0.7	0.79	0.97	0.77	-0.67	0.86	0.79	0.9	-0.72
Long Term Debt	0.9	0.87	0.57	0.84	0.85	0.41	0.46	0.92	0.88		0.76	0.9	0.76	-0.71	0.86	0.64	0.83	0.9	0.75	-0.76	0.83	0.68	0.78	-0.49
Net Receivables	0.83	0.82	0.39	0.75	0.79	0.71	0.36	0.81	0.78	0.76		0.84	0.66	-0.88	0.79	0.91	0.78	0.79	0.9	-0.52	0.83	0.74	0.62	-0.2
Good Will	0.98	0.96	0.63	0.9	0.91	0.6	0.47	0.97	0.92	0.9	0.84		0.81	-0.8	0.97	0.73	0.89	0.95	0.84	-0.74	0.94	0.76	0.89	-0.52
Short Term Investments	0.9	0.93	0.24	0.54	0.95	0.21	0.01	0.91	0.89	0.76	0.66	0.81		-0.6	0.69	0.54	0.81	0.93	0.82	-0.71	0.86	0.9	0.94	-0.72
Treasury Stock	-0.8	-0.8	-0.25	-0.7	-0.77	-0.63	-0.34	-0.75	-0.77	-0.71	-0.88	-0.8	-0.6		-0.74	-0.97	-0.77	-0.73	-0.7	0.36	-0.67	-0.55	-0.6	0.25
Intangible Assets	0.92	0.87	0.74	0.93	0.8	0.67	0.59	0.89	0.82	0.86	0.79	0.97	0.69	-0.74		0.67	0.85	0.86	0.79	-0.72	0.91	0.68	0.82	-0.39
Common Stock	0.74	0.74	0.16	0.63	0.72	0.66	0.31	0.69	0.7	0.64	0.91	0.73	0.54	-0.97	0.67		0.73	0.67	0.71	-0.33	0.63	0.54	0.5	-0.16
Property Plant Equipment	0.89	0.89	0.43	0.69	0.85	0.42	0.49	0.88	0.79	0.83	0.78	0.89	0.81	-0.77	0.85	0.73		0.86	0.82	-0.67	0.83	0.72	0.81	-0.41
Net Tangible Assets	0.99	0.98	0.47	0.79	0.98	0.42	0.26	1.0	0.97	0.9	0.79	0.95	0.93	-0.73	0.86	0.67	0.86		0.85	-0.77	0.92	0.84	0.94	-0.67
Capital Surpluse	0.86	0.87	0.4	0.63	0.84	0.53	0.26	0.85	0.77	0.75	0.9	0.84	0.82	-0.7	0.79	0.71	0.82	0.85		-0.7	0.94	0.93	0.78	-0.31
Deferred Long Term Liab	-0.74	-0.73	-0.5	-0.6	-0.7	-0.27	-0.32	-0.77	-0.67	-0.76	-0.52	-0.74	-0.71	0.36	-0.72	-0.33	-0.67	-0.77	-0.7		-0.78	-0.69	-0.75	0.44
Net Invested Capital	0.93	0.93	0.57	0.77	0.89	0.57	0.32	0.93	0.86	0.83	0.83	0.94	0.86	-0.67	0.91	0.63	0.83	0.92	0.94	-0.78		0.92	0.91	-0.48
Net Working Capital	0.83	0.86	0.27	0.5	0.86	0.39	0.0	0.83	0.79	0.68	0.74	0.76	0.9	-0.55	0.68	0.54	0.72	0.84	0.93	-0.69	0.92		0.86	-0.52
Capital Stock	0.93	0.95	0.44	0.68	0.94	0.33	0.16	0.93	0.9	0.78	0.62	0.89	0.94	-0.6	0.82	0.5	0.81	0.94	0.78	-0.75	0.91	0.86		-0.75
Short Long Term Debt	-0.63	-0.64	-0.11	-0.4	-0.71	-0.05	0.2	-0.64	-0.72	-0.49	-0.2	-0.52	-0.72	0.25	-0.39	-0.16	-0.41	-0.67	-0.31	0.44	-0.48	-0.52	-0.75

Click cells to compare fundamentals

In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.

Competition

Predict LeMaitre Vascular

Ebitda Over Time

LeMaitre Ebitda

Ebitda

51.44 Million

At this time, LeMaitre Vascular's EBITDA is comparatively stable compared to the past year.

According to the company disclosure, LeMaitre Vascular reported earnings before interest,tax, depreciation and amortization of 48.99 M. This is 94.42% lower than that of the Health Care Equipment & Supplies sector and 89.59% lower than that of the Health Care industry. The ebitda for all United States stocks is 98.74% higher than that of the company.

LeMaitre EBITDA Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses LeMaitre Vascular's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of LeMaitre Vascular could also be used in its relative valuation, which is a method of valuing LeMaitre Vascular by comparing valuation metrics of similar companies.

LeMaitre Vascular is currently under evaluation in ebitda category among its peers.

LeMaitre Vascular ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, LeMaitre Vascular's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to LeMaitre Vascular's managers, analysts, and investors.

Environmental

Governance

Social

LeMaitre Vascular Institutional Holders

Institutional Holdings refers to the ownership stake in LeMaitre Vascular that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of LeMaitre Vascular's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing LeMaitre Vascular's value.

		Shares
Northern Trust Corp	2024-09-30	312 K
T. Rowe Price Associates, Inc.	2024-06-30	279.3 K
Acadian Asset Management Llc	2024-06-30	277.5 K
Driehaus Capital Management Llc	2024-06-30	264.2 K
Rice Hall James & Associates, Llc	2024-09-30	261.3 K
Ameriprise Financial Inc	2024-06-30	257.4 K
Envestnet Asset Management Inc	2024-09-30	242.5 K
Bank Of New York Mellon Corp	2024-06-30	210.6 K
Df Dent & Co Inc	2024-06-30	205 K
Blackrock Inc	2024-06-30	3.5 M
Conestoga Capital Advisors, Llc	2024-09-30	2 M

LeMaitre Fundamentals

	Return On Equity	0.13
	Return On Asset	0.0872
	Profit Margin	0.19 %
	Operating Margin	0.24 %
	Current Valuation	2.3 B
	Shares Outstanding	22.48 M
	Shares Owned By Insiders	8.85 %
	Shares Owned By Institutions	94.30 %
	Number Of Shares Shorted	756.31 K
	Price To Earning	38.99 X
	Price To Book	7.27 X
	Price To Sales	11.29 X
	Revenue	193.48 M
	Gross Profit	104.9 M
	EBITDA	48.99 M
	Net Income	30.11 M
	Cash And Equivalents	75.68 M
	Cash Per Share	3.45 X
	Total Debt	19.09 M
	Debt To Equity	0.07 %
	Current Ratio	6.34 X
	Book Value Per Share	14.72 X
	Cash Flow From Operations	36.75 M
	Short Ratio	5.60 X
	Earnings Per Share	1.82 X
	Price To Earnings To Growth	2.35 X
	Target Price	98.78
	Number Of Employees	614
	Beta	0.89
	Market Capitalization	2.41 B
	Total Asset	346.78 M
	Retained Earnings	115.43 M
	Working Capital	164.72 M
	Current Asset	58.18 M
	Current Liabilities	10.37 M
	Annual Yield	0.01 %
	Five Year Return	0.93 %
	Net Asset	346.78 M
	Last Dividend Paid	0.62

About LeMaitre Vascular Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze LeMaitre Vascular's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of LeMaitre Vascular using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of LeMaitre Vascular based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for LeMaitre Stock Analysis

When running LeMaitre Vascular's price analysis, check to measure LeMaitre Vascular's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LeMaitre Vascular is operating at the current time. Most of LeMaitre Vascular's value examination focuses on studying past and present price action to predict the probability of LeMaitre Vascular's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LeMaitre Vascular's price. Additionally, you may evaluate how the addition of LeMaitre Vascular to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC